EHP Funds Inc’s Pfizer PFE Stock Holding History

EHP Funds Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,000	Closed	-$317K	–	195
2023 Q4	$317K	Buy	11,000 +1,000	+10%	+$30.2K	0.12%	109
2023 Q3	$332K	Sell	10,000 -6,400	-39%	-$226K	0.16%	97
2023 Q2	$602K	Sell	16,400 -13,700	-46%	-$533K	0.15%	120
2023 Q1	$1.23M	Sell	30,100 -50,200	-63%	-$2.17M	0.24%	95
2022 Q4	$4.12M	Sell	80,300 -6,900	-8%	-$331K	0.78%	40
2022 Q3	$3.82M	Buy	87,200 +3,000	+4%	+$146K	0.77%	48
2022 Q2	$4.42M	Buy	84,200 +27,200	+48%	+$1.39M	0.73%	37
2022 Q1	$2.95M	Buy	+57,000	New	+$2.96M	0.49%	93

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EHP Funds Inc's PFE Position: Q1 2024 in Review

EHP Funds Inc sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,000 shares — an estimated $317K sold.

EHP Funds Inc first reported a position in PFE in Q1 2022 and held it in 8 quarters. The position peaked at $4.42M in Q2 2022. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

EHP Funds Inc reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
EHP Funds Inc sold 11,000 Pfizer shares in Q1 2024, an estimated $317K.
EHP Funds Inc first reported a position in Pfizer in Q1 2022 and held it in 8 quarters.
EHP Funds Inc's Pfizer position peaked at $4.42M in Q2 2022.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on EHP Funds Inc's 13F filing for Q1 2024, filed 15 May 2024.